Charles Schwab Investment Management Inc. lifted its holdings in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,235,051 shares of the company's stock after purchasing an additional 89,926 shares during the quarter. Charles Schwab Investment Management Inc. owned about 1.42% of American Healthcare REIT worth $67,722,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Wolff Wiese Magana LLC acquired a new stake in American Healthcare REIT during the first quarter worth about $25,000. MassMutual Private Wealth & Trust FSB increased its position in American Healthcare REIT by 189.0% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock worth $29,000 after purchasing an additional 633 shares in the last quarter. Spirit of America Management Corp NY purchased a new position in American Healthcare REIT in the first quarter valued at approximately $30,000. Avalon Trust Co acquired a new position in American Healthcare REIT during the first quarter valued at approximately $36,000. Finally, Continuum Advisory LLC acquired a new stake in shares of American Healthcare REIT in the first quarter worth $37,000. Hedge funds and other institutional investors own 16.68% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on AHR. Morgan Stanley upped their target price on American Healthcare REIT from $37.00 to $45.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 20th. Royal Bank Of Canada set a $45.00 price target on American Healthcare REIT and gave the stock an "outperform" rating in a research report on Wednesday, August 13th. Jefferies Financial Group began coverage on shares of American Healthcare REIT in a research report on Monday, April 28th. They issued a "buy" rating and a $37.00 price objective for the company. Scotiabank started coverage on shares of American Healthcare REIT in a research note on Monday, June 30th. They set a "sector outperform" rating and a $42.00 price objective on the stock. Finally, Baird R W upgraded shares of American Healthcare REIT to a "strong-buy" rating in a research note on Thursday, July 17th. Ten analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $41.11.
Check Out Our Latest Analysis on AHR
Insiders Place Their Bets
In other American Healthcare REIT news, CIO Stefan K.L. Oh sold 3,860 shares of American Healthcare REIT stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of $36.10, for a total value of $139,346.00. Following the completion of the transaction, the executive directly owned 95,671 shares in the company, valued at $3,453,723.10. The trade was a 3.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.92% of the stock is currently owned by insiders.
American Healthcare REIT Stock Down 0.8%
Shares of AHR stock traded down $0.32 during trading hours on Tuesday, hitting $40.56. 183,670 shares of the company were exchanged, compared to its average volume of 1,629,066. The stock has a market capitalization of $6.84 billion, a price-to-earnings ratio of -184.68, a P/E/G ratio of 2.24 and a beta of 1.08. American Healthcare REIT, Inc. has a one year low of $19.26 and a one year high of $41.50. The business's 50-day simple moving average is $37.54 and its two-hundred day simple moving average is $33.22. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.48 and a current ratio of 0.48.
American Healthcare REIT (NYSE:AHR - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.02. The company had revenue of $542.50 million for the quarter, compared to the consensus estimate of $539.49 million. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%. American Healthcare REIT's quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.33 EPS. Sell-side analysts predict that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.
American Healthcare REIT Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, July 18th. Shareholders of record on Monday, June 30th were paid a dividend of $0.25 per share. The ex-dividend date was Monday, June 30th. This represents a $1.00 annualized dividend and a yield of 2.5%. American Healthcare REIT's payout ratio is presently -454.55%.
American Healthcare REIT Company Profile
(
Free Report)
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Recommended Stories

Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.